Evidence map›Paper›PMID 18646185›Full record

ArticleInternational journal of cancer2008

Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations.

Sally L Glaser, Margaret L Gulley, Christina A Clarke, Theresa H Keegan, Ellen T Chang, Sarah J Shema, Fiona E Craig, Joseph A Digiuseppe, Ronald F Dorfman, Risa B Mann and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. A Systematic Review on Clinico-Aetiopathological Trends of Nasopharyngeal Cancer in Asia.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  5. Article
  6. Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future.International journal of molecular sciences · 2020
    Review
  7. Article
  8. Epidemiology and Etiology of Leukemia and Lymphoma.Cold Spring Harbor perspectives in medicine · 2020
    Review
  9. Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children's Oncology Group Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2019
    Article
  10. Prevalence of Epstein–Barr Virus Genotypes in Pakistani Lymphoma PatientsAsian Pacific journal of cancer prevention : APJCP · 2018
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Cancers in Australia in 2010 attributable to infectious agents.Australian and New Zealand journal of public health · 2015
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Sally L GlaserNorthern California Cancer Center, Fremont, CA 94538, USA. sglaser@nccc.org
Margaret L Gulley
Christina A Clarke
Theresa H Keegan
Ellen T Chang
Sarah J Shema
Fiona E Craig
Joseph A Digiuseppe
Ronald F Dorfman
Risa B Mann
Hoda Anton-Culver
Richard F Ambinder
Stanford University · USCancer Prevention Institute of California · USJohns Hopkins University · USHartford Hospital · USNiagara County Community College · USUniversity of California, Irvine · USUniversity of North Carolina at Chapel Hill · USUniversity of Pittsburgh · US

Funding

Treatment of lymphoma by death receptor induced apoptosisP50CA096888 · NCI · JOHNS HOPKINS UNIVERSITY · PI AMBINDER, RICHARD FREDERICK · 2002 to 2009
$13.6M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC065107 · PC · NORTHERN CALIFORNIA CANCER CENTER · PI WEST, DEE WAYNE · 1996 to 2000
$1.9M
EPIDEMIOLOGY OF EBV DEFINED HODGKINS DISEASER01CA065661 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI GLASER, SALLY L · 1997 to 1999
–
EPSTEIN-BARR VIRUS IN HODGKIN'S DISEASER03CA063245 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI GLASER, SALLY L · 1994 to 1995
–
NCI NIH HHS N01 PC035136NCI NIH HHS N01-PC-65107NCI NIH HHS N02 PC015105NCI NIH HHS P50 CA096888NCI NIH HHS P50CA096888NCI NIH HHS R01 CA065661NCI NIH HHS R01CA65661NCI NIH HHS R03CA63245
6 · The paper itself

Abstract

Epstein-Barr virus (EBV) is detected in the tumor cells of some but not all Hodgkin lymphoma (HL) patients, and evidence indicates that EBV-positive and -negative HL are distinct entities. Racial/ethnic variation in EBV-positive HL in international comparisons suggests etiologic roles for environmental and genetic factors, but these studies used clinical series and evaluated EBV presence by differing protocols. Therefore, we evaluated EBV presence in the tumors of a large (n = 1,032), racially and sociodemographically diverse series of California incident classical HL cases with uniform pathology re-review and EBV detection methods. Tumor EBV-positivity was associated with Hispanic and Asian/Pacific Islander (API) but not black race/ethnicity, irrespective of demographic and clinical factors. Complex race-specific associations were observed between EBV-positive HL and age, sex, histology, stage, neighborhood socioeconomic status (SES), and birth place. In Hispanics, EBV-positive HL was associated not only with young and older age, male sex, and mixed cellularity histology, but also with foreign birth and lower SES in females, suggesting immune function responses to correlates of early childhood experience and later environmental exposures, respectively, as well as of pregnancy. For APIs, a lack of association with birth place may reflect the higher SES of API than Hispanic immigrants. In blacks, EBV-positive HL was associated with later-stage disease, consistent with racial/ethnic variation in certain cytokine polymorphisms. The racial/ethnic variation in our findings suggests that EBV-positive HL results from an intricate interplay of early- and later-life environmental, hormonal, and genetic factors leading to depressed immune function and poorly controlled EBV infection.

Indexed as

EthnicityRacial GroupsAdolescentAdultAgedAged, 80 and overCaliforniaChildChild, PreschoolFemaleGenetic VariationHerpesvirus 4, HumanHodgkin DiseaseHumansInfantInfant, Newborn

Identifiers

PMID18646185
PMCPMC2775059
OpenAlexW2164955953

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.